Venture Capital in Switzerland – HBM Partners AG

HBM BioVentures is a leading holding company in the human medicine, biotech and medical technology industries. It enables investors to tap in to a broadly diversified portfolio of private and primarily small-cap public companies with high value creation potential in an investment segment that is difficult to access. HBM BioVentures is recognised as a complement to traditional pharmaceutical and biotech investments. HBM BioVentures is an active investor which finances, supports and shapes portfolio companies as a key partner. With net assets of over CHF 1 billion, HBM BioVentures is a market leader in its sector. HBM BioVentures Ltd is domiciled in Baar, Switzerland, and has a broad shareholder base. HBM BioVentures shares are traded over the counter. © HBM Partners